Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biopol ChemicalsNSE:BIOPOL +0.31%20 ROE % is 38.07% as of Mar. 2026, which is 18% above its 10-year median of 32.19. GuruFocus rates NSE:BIOPOL with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 1,583 Chemicals companies, Biopol Chemicals ranks better than 91.6% on this metric.
The historical rank and industry rank for Biopol Chemicals's ROE % or its related term are showing as below:
NSE:BIOPOL'
s ROE % Range Over the Past 10 Years
Min: 19.04 Med: 32.19 Max: 37.94
Current: 19.04
During the past 3 years, Biopol Chemicals's highest ROE % was 37.94%. The lowest was 19.04%. And the median was 32.19%.
NSE:BIOPOL's ROE % is ranked better than 91.6% of 1583
companies
in the Chemicals industry
Industry Median: 5.26
vs NSE:BIOPOL: 19.04
Biopol Chemicals (NSE:BIOPOL) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Biopol Chemicals ROE % Related Terms
Biopol Chemicals ROE % Historical Data
* Premium members only.
The historical data trend for Biopol Chemicals's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biopol Chemicals ROE % Chart
Biopol Chemicals Annual Data
Trend
Mar24
Mar25
Mar26
ROE %
32.19
37.94
28.29
Biopol Chemicals Semi-Annual Data
Mar24
Mar25
Mar26
ROE %
0.00
52.80
38.07
NSE:BIOPOL vs LIN, SHW, ECL: ROE % Comparison
For the Specialty Chemicals subindustry, Biopol Chemicals's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biopol Chemicals ROE % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Biopol Chemicals's ROE % distribution charts can be found below:
* The bar in red indicates where Biopol Chemicals's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Biopol Chemicals (NSE:BIOPOL) has a ROE % of 38.07% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Biopol Chemicals and its competitors. This is 18% above median its historical median of 32.19. Over the past decade, Biopol Chemicals' ROE % has ranged from 19.04 to 37.94. According to the industry distribution chart, Biopol Chemicals ranks #133 out of 1583 companies in the Chemicals industry, placing it in the top 8.4%.
Is Biopol Chemicals' ROE % too high?
Biopol Chemicals' current ROE % of 38.07% is 18% above median its 10-year median of 32.19. Over the past 10 years, this metric has ranged from a low of 19.04 to a high of 37.94. The Chemicals industry median ROE % is 5.26. Biopol Chemicals' value of 38.07% is 623.8% above this industry median. Based on the distribution chart, Biopol Chemicals ranks #133 out of 1583 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Biopol Chemicals has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Biopol Chemicals' ROE % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Biopol Chemicals ranks #133 out of 1583 companies for ROE %. This places Biopol Chemicals in the top 8% of its industry — outperforming the majority of peers. The industry median ROE % is 5.26. Biopol Chemicals' value of 38.07% is 623.8% above this benchmark. Historically, Biopol Chemicals' own ROE % has ranged from 19.04 to 37.94 over the past decade. While the company's 10-year median is 32.19 vs. the industry median of 5.26, Biopol Chemicals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Chemicals company?
The median ROE % among Chemicals companies is 5.26, based on 1,583 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biopol Chemicals's current ROE % of 38.07% is 623.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Biopol Chemicals and its competitors. For the Chemicals industry, the median ROE % is 5.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biopol Chemicals's current ROE % is 38.07%, which is 18% above median its own 10-year median of 32.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biopol Chemicals stock overvalued right now?
Biopol Chemicals (NSE:BIOPOL) has a current ROE % of 38.07%. The current ROE % is 38.07%, which is 18% above median its 10-year median of 32.19 and 623.8% above the Chemicals industry median of 5.26. Biopol Chemicals' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Biopol Chemicals (NSE:BIOPOL), the current ROE % is 38.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressStreet No 372 Action Area 1, Unit No 2ES3B1, 2nd Floor Mani Casadona, IIF Newtown Alia University, North 24 Parganas, Chakpachuria, New town, WB, IND, 700160
Biopol Chemicals Ltd is engaged in the business of trading, manufacturing and distribution of specialty chemicals under the categories of silicones, emulsifiers, biochemicals and polyelectrolytes. Its product portfolio consists of silicone-based products, emulsifier-based products, biochemical products and polyelectrolyte products. It serves various industry segments, including softeners, emulsions and hardeners for textiles; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants in agriculture; and release agents in industrial chemicals. The majority of the company's revenue is derived from the sale of its products to customers in the textile sector.
20GF Score
Get the complete analysis for NSE:BIOPOL
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BIOPOL has been successfully added to your 
